Concepedia

Ester Schallmach

ES

Statistics

Publications

7

Citations

471

H-Index

7

Active since

2001

Affiliations

Weizmann Institute of Science(Current)

Sheba Medical Center

Technion – Israel Institute of Technology

Ester Schallmach is an author at Weizmann Institute of Science specializing in life sciences, adenylyl cyclase regulation, and adenylyl cyclase signaling.

Publications per year

2001–2009

7

Publications

7

D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties

Marco Scarselli, Francesca Novi, Ester Schallmach et al. · Journal of Biological Chemistry · 2001 · 216 citations · Full text

, , +17

Minimally Cultured or Selected Autologous Tumor-infiltrating Lymphocytes After a Lympho-depleting Chemotherapy Regimen in Metastatic Melanoma Patients

Michal J. Besser, Ronnie Shapira‐Frommer, Avraham J. Treves et al. · Journal of Immunotherapy · 2009 · 120 citations

, , +17

Adenylyl cyclase type-VIII activity is regulated by Gβγ subunits

Debora Steiner, Daniella Saya, Ester Schallmach et al. · Cellular Signalling · 2005 · 49 citations

, , +9

Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy

Michal J. Besser, Ester Schallmach, Kfir Oved et al. · Cytotherapy · 2009 · 32 citations

, , +16

Adenylyl cyclase type II activity is regulated by two different mechanisms: Implications for acute and chronic opioid exposure

Ester Schallmach, Debora Steiner, Zvi Vogel · Neuropharmacology · 2006 · 20 citations

, , +9

1–5 of 7